SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness
- PMID: 34139198
- PMCID: PMC8201647
- DOI: 10.1016/S0140-6736(21)01358-1
SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness
Conflict of interest statement
AS, JM, and CR are members of the Scottish Government's COVID-19 Advisory Group. AS and CR are members of the New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG) risk stratification subgroup. JM is a member of NERVTAG. CR is a member of the Scientific Pandemic Influenza Group on Modelling. AS is a member of AstraZeneca's Thrombotic Thrombocytopenic Advisory Group. All roles are unremunerated. JM, BT, and CR are employed by Public Health Scotland. Acknowledgments are listed in the appendix.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous